ArticleUrolithiasis2026
Inverse association between the C-reactive protein-to-albumin-to-lymphocyte (CALLY) index and kidney stones in US adults: a population-based study.
Article in Urolithiasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The C-reactive protein-albumin-lymphocyte (CALLY) index is an emerging integrated biomarker that simultaneously captures systemic inflammation, immune function, and nutritional status. This study investigates the potential association between the CALLY index and the occurrence of kidney stones. This cross-sectional study utilized data obtained from the 2007–2010 NHANES. Weighted logistic regression and nonlinear regression analysis were applied to analyze the relationship between the CALLY index and kidney stones. The robustness of the results was further examined through subgroup analyses. Predictive performance was assessed through ROC curves. Of the 10,698 participants aged 18 and above, 9.15% reported a history of kidney stones. After log-transforming the CALLY index, the multivariable-adjusted model revealed that each one-unit increase in lnCALLY was associated with a 22% reduction in the risk of kidney stones (OR = 0.78; 95% CI: 0.64–0.96; P = 0.0170). Subgroup analyses and nonlinear regression analysis are used to validate this association further. Finally, the ROC curve analysis indicated that the CALLY index outperformed SII, SIRI, NLR, MLR, PIV, and PLR in estimating the risk of kidney stones. This study suggests that lower CALLY levels appear to be linked to a higher likelihood of developing kidney stones. Future studies should explore longitudinal effects and intervention outcomes to further elucidate the potential benefits of CALLY-related indicators in reducing the risk of kidney stones.
Indexed as
Identifiers
42012638What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.